Published in Cancer Weekly, July 26th, 2005
Xantos has used XantoScreen technology to discover novel proteins that mediate proliferation of vascular endothelial cells, which potentially play a role in the formation of new blood vessels (angiogenesis) of tumors.
Newly identified secreted proteins out of this screen have provided targets for inhibitory approaches aimed at depriving tumor cells from nutrients and oxygen. Simultaneously, such proteins may also serve as leads for the promotion of the growth of new blood vessels.
Cryptome (CRP) has...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.